Regeneron Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2026, Regeneron Pharmaceuticals Inc has not recorded any inventories.
Visit Regeneron Pharmaceuticals Inc Balance sheet

Within Healthcare sector 354 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1948, from total ranking in the second quarter 2026 at 2183.

REGN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Regeneron Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

REGN Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	-11.06 %	-3.78 %	-2.78 %	3.68 %	7.83 %
Y / Y Cost of Sales Growth	-	109.18 %	40.64 %	-2.48 %	7.13 %
Inventory Turnover Ratio (TTM)	-	0.49	0.39	0.36	0.36
REGN's Total Ranking	# 1948	# 2183	# 2008	# 2020	# 2031
Average inventory processing period	-	745	933	1028	1012
Seq. Inventory Growth	-6.15 %	-0.62 %	-3.04 %	-1.65 %	1.52 %
Seq. Cost of Sales Growth	-	54.39 %	17.16 %	13.42 %	1.96 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 112
Healthcare Sector	# 355
Overall Market	# 1948

Inventory Turnover Ratio Statistics
High	Average	Low
1.38	0.54	0.16
(Sep 30 2014)		(Mar 31 2019)

REGN Company Profile >> Back to REGN Efficiency Comparisons >> Compare REGN Inventory Turnover Ratio to its Competitors

Financial Statements
Regeneron Pharmaceuticals Inc 's Inventories	$ 2,895 Millions	Visit REGN's Balance sheet
Regeneron Pharmaceuticals Inc 's Cost of Revenues TTM	$ 1,269 Millions	Visit REGN's Income Statement
What are REGN's Sales?		Visit REGN's Sales by Segment

Other Inventory Turnover Ratios
Regeneron Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
REGN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for REGN's Competitors
Inventory Turnover Ratio for REGN's Suppliers
Inventory Turnover Ratio for REGN's Customers

You may also want to know
REGN's Sales Growth Rates	REGN's Pe Price to earnings ratio	REGN's Receivables Turnover Ratio	REGN's Stock Quote
REGN's Net Income Growth Rates	REGN's Ps Price to Sales ratio	REGN's Sales per Employee	REGN's Asset Turnover Ratio
REGN's Net Margin	REGN's Pb Price to Book ratio	REGN's Financial Strength Ratios	REGN's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Penumbra Inc	1.13	$ 499.548 Millions	$ 443 Millions
Amarin Corp Plcuk	0.92	$ 104.502 Millions	$ 113 Millions
Eli Lilly And Company	0.89	$ 14,149.700 Millions	$ 15,815 Millions
Butterfly Network Inc	0.62	$ 37.120 Millions	$ 60 Millions
Orthopediatrics Corp	0.50	$ 68.827 Millions	$ 137 Millions

Date modified: 2026-10-31T08:48:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.